Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesIn situ neoplasmsICD-10-CM d06-carcinoma-in-situ-of-cervix-uteri
    Ask Trek AI about this page

    ICD-10-CM Code For Carcinoma In Situ Of Cervix Uteri: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group D06 includes diagnoses for noninvasive malignant epithelial neoplasms of the cervix uteri, covering carcinoma in situ of the endocervix, exocervix, and unspecified portions of the cervix. These ICD-10-CM diagnosis codes are used to document the presence and anatomic site of in situ cervical neoplasia, capturing disease localization and noninvasive status relevant to treatment planning and registry reporting. Accurate coding within the ICD-10-CM D06 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Carcinoma In Situ Of Cervix Uteri: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM D06: Carcinoma In Situ Of Cervix Uteri Overview

    The carcinoma in situ of cervix uteri group represents noninvasive malignant epithelial neoplasms confined to the cervix. These diagnoses target the female reproductive system and specifically the cervical epithelium. Accurate coding matters for clinical records, cancer registries, and appropriate reimbursement because it distinguishes in situ disease from invasive cancer.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use a code from this group when documentation indicates carcinoma in situ of the cervix uteri and specifies the anatomic site when available. These codes apply when the neoplasm is noninvasive and confined to the cervical epithelium rather than invasive cervical cancer.

    ICD-10-CM Codes

    4 rows

    ICD-10-CM CodeDescription
    D06.0Carcinoma in situ of endocervix
    D06.1Carcinoma in situ of exocervix
    D06.7Carcinoma in situ of other parts of cervix
    D06.9Carcinoma in situ of cervix, unspecified

    DRG Codes

    9 rows

    DRG CodeDescription
    736Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC
    737Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with CC
    738Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy without CC/MCC
    739Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC
    740Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC
    741Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy without CC/MCC
    754Malignancy, Female Reproductive System with MCC
    755Malignancy, Female Reproductive System with CC
    756Malignancy, Female Reproductive System without CC/MCC

    Typical Clinical Scenarios

    • A 32-year-old woman presents to gynecology after an abnormal cervical cytology (Pap) showing high-grade squamous intraepithelial lesion (HSIL) and positive high-risk HPV testing. Colposcopic exam with directed biopsy confirms carcinoma in situ limited to the exocervix without stromal invasion, prompting discussion of excisional treatment options; a code from this group is assigned to indicate in situ neoplasia of the cervix. Typical codes: D06.0, D06.1
    • A 48-year-old woman with a history of abnormal Pap smears undergoes loop electrosurgical excision procedure (LEEP) for a lesion involving both the endocervical canal and ectocervix; surgical pathology reports carcinoma in situ of the endocervix. The patient presents for postoperative follow-up and surveillance; an in situ cervical neoplasm code specifying endocervical involvement is used for documentation and ongoing management. Typical codes: D06.1
    • A 67-year-old woman is evaluated for abnormal vaginal bleeding and found on biopsy to have carcinoma in situ of the cervix not otherwise specified; she has multiple comorbidities that complicate definitive surgical therapy and requires nonoperative management and close surveillance. Because the pathology demonstrates in situ disease but the exact location within the cervix is not detailed, an unspecified in situ cervix code from this group is assigned to capture the diagnosis as a comorbidity affecting treatment decisions. Typical codes: D06.9, D06.7

    Related Codes

    D00-CARCINOMA-IN-SITU-ORAL-ESOPHAGUS-STOMACH

    ICD-10-CM Code For Carcinoma In Situ Of Oral Cavity, Esophagus And Stomach: Group Overview

    D01-CARCINOMA-IN-SITU-DIGESTIVE

    ICD-10-CM Code For Carcinoma In Situ Of Other And Unspecified Digestive Organs: Group Overview

    D02-CARCINOMA-IN-SITU-MIDDLE-EAR-RESPIRATORY

    ICD-10-CM Code For Carcinoma In Situ Of Middle Ear And Respiratory System: Group Overview

    D03-MELANOMA-IN-SITU

    ICD-10-CM Code For Melanoma In Situ: Group Overview

    D04-CARCINOMA-IN-SITU-OF-SKIN

    ICD-10-CM Code For Carcinoma In Situ Of Skin: Group Overview

    D05-CARCINOMA-IN-SITU-OF-BREAST

    ICD-10-CM Code For Carcinoma In Situ Of Breast: Group Overview

    D07-CARCINOMA-IN-SITU-GENITAL-ORGANS

    ICD-10-CM Code For Carcinoma In Situ Of Other And Unspecified Genital Organs: Group Overview

    D09-CARCINOMA-IN-SITU-OTHER-UNSPECIFIED-SITES

    ICD-10-CM Code For Carcinoma In Situ Of Other And Unspecified Sites: Group Overview

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.